Medicaid Analysis of Substances of Abuse for Patients With Crohn's Disease.
作者信息
Yacyshyn Sara E, Yacyshyn Bruce R
机构信息
Wright State University, Boonshoft School of Medicine, Dayton, Ohio.
Department of Pharmacology and Systems Physiology, University of Cincinnati School of Medicine, Cincinnati, Ohio.
出版信息
Gastro Hep Adv. 2023 Jul 25;2(6):875-876. doi: 10.1016/j.gastha.2023.07.015. eCollection 2023.
Abstract
摘要
相似文献
1
Medicaid Analysis of Substances of Abuse for Patients With Crohn's Disease.
Gastro Hep Adv. 2023 Jul 25;2(6):875-876. doi: 10.1016/j.gastha.2023.07.015. eCollection 2023.
2
Linoleic acid, but not oleic acid, upregulates the production of interleukin-8 by human intestinal smooth muscle cells isolated from patients with Crohn's disease.
Clin Nutr. 2003 Dec;22(6):529-35. doi: 10.1016/s0261-5614(03)00083-9.
3
Enhanced absorption of macromolecules. A secondary factor in Crohn's disease.
Dig Dis Sci. 1996 Jul;41(7):1423-8. doi: 10.1007/BF02088568.
4
Concomitant active Crohn's disease and the acquired immunodeficiency syndrome.
Scand J Gastroenterol. 1996 Jul;31(7):733-5. doi: 10.3109/00365529609009158.
5
Oxidative stress, vitamin A and vitamin E behaviour in patients submitted to conservative surgery for complicated Crohn's disease.
Dig Liver Dis. 2002 Oct;34(10):696-701. doi: 10.1016/s1590-8658(02)80020-2.
6
Association Between Cannabis Use and Complications Related to Crohn's Disease: A Retrospective Cohort Study.
Dig Dis Sci. 2019 Oct;64(10):2939-2944. doi: 10.1007/s10620-019-05556-z. Epub 2019 Mar 2.
7
Concepts of oxidative stress and antioxidant defense in Crohn's disease.
World J Gastroenterol. 2013 Oct 21;19(39):6540-7. doi: 10.3748/wjg.v19.i39.6540.
8
Tobacco use in Crohn's disease patients and association with disease outcomes in the United States Medicaid population, 2010-2019.
JGH Open. 2023 Mar 31;7(4):291-298. doi: 10.1002/jgh3.12893. eCollection 2023 Apr.
9
10
ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability.
J Control Release. 2013 Dec 28;172(3):618-24. doi: 10.1016/j.jconrel.2013.09.021. Epub 2013 Oct 2.
本文引用的文献
1
Substance Use Among Patients With Incident Crohn's Disease in the United States, 2010 to 2019: A Medicaid Observational Study.
Gastro Hep Adv. 2023;2(6):747-754. doi: 10.1016/j.gastha.2023.03.019. Epub 2023 Mar 17.
2
Trends in hospital admissions and mortality among inflammatory bowel disease patients with substance use disorder: a 10-year United States nationwide analysis.
Proc (Bayl Univ Med Cent). 2023 May 3;36(4):427-433. doi: 10.1080/08998280.2023.2204535. eCollection 2023.
3
Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chronic Abdominal Pain Associated With Crohn's Disease.
Crohns Colitis 360. 2020 Oct 24;3(1):otaa089. doi: 10.1093/crocol/otaa089. eCollection 2021 Jan.
4
Use of Cannabis and Other Pain Treatments Among Adults With Chronic Pain in US States With Medical Cannabis Programs.
JAMA Netw Open. 2023 Jan 3;6(1):e2249797. doi: 10.1001/jamanetworkopen.2022.49797.
5
The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
BMC Gastroenterol. 2022 Jul 30;22(1):366. doi: 10.1186/s12876-022-02430-7.
6
Polysubstance use in inflammatory bowel disease.
J Dig Dis. 2021 Dec;22(12):706-713. doi: 10.1111/1751-2980.13064. Epub 2021 Nov 28.
7
Alcohol and narcotics use in inflammatory bowel disease.
Ann Gastroenterol. 2018 Nov-Dec;31(6):649-658. doi: 10.20524/aog.2018.0302. Epub 2018 Aug 1.
8
Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease.
Pharmaceuticals (Basel). 2010 Apr 12;3(4):1084-1092. doi: 10.3390/ph3041084.
9
Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.
PLoS One. 2016 Jun 22;11(6):e0156666. doi: 10.1371/journal.pone.0156666. eCollection 2016.
10
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
Zotero 插件